ATE533059T1 - Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse - Google Patents

Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse

Info

Publication number
ATE533059T1
ATE533059T1 AT07847829T AT07847829T ATE533059T1 AT E533059 T1 ATE533059 T1 AT E533059T1 AT 07847829 T AT07847829 T AT 07847829T AT 07847829 T AT07847829 T AT 07847829T AT E533059 T1 ATE533059 T1 AT E533059T1
Authority
AT
Austria
Prior art keywords
kits
proteins
highly sensitive
biological interest
immune tests
Prior art date
Application number
AT07847829T
Other languages
English (en)
Inventor
Barrio J Manuel Sarasa
Original Assignee
Araclon Biotech Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38544110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533059(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Araclon Biotech Sl filed Critical Araclon Biotech Sl
Application granted granted Critical
Publication of ATE533059T1 publication Critical patent/ATE533059T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07847829T 2007-08-02 2007-12-05 Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse ATE533059T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07380227A EP2020602A1 (de) 2007-08-02 2007-08-02 Hochempfindliche Immuntests und Kits zur Bestimmung biologisch interessanter Peptide und Proteine
PCT/EP2007/063334 WO2009015696A1 (en) 2007-08-02 2007-12-05 High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest

Publications (1)

Publication Number Publication Date
ATE533059T1 true ATE533059T1 (de) 2011-11-15

Family

ID=38544110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07847829T ATE533059T1 (de) 2007-08-02 2007-12-05 Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse

Country Status (23)

Country Link
US (2) US20090035790A1 (de)
EP (2) EP2020602A1 (de)
JP (1) JP5657382B2 (de)
KR (1) KR101461538B1 (de)
CN (1) CN101861521B (de)
AR (1) AR064186A1 (de)
AT (1) ATE533059T1 (de)
AU (1) AU2007357025B2 (de)
BR (1) BRPI0721871A2 (de)
CA (1) CA2689024C (de)
CL (1) CL2007003513A1 (de)
CY (1) CY1112553T1 (de)
DK (1) DK2183599T3 (de)
ES (1) ES2377151T3 (de)
HR (1) HRP20120020T1 (de)
IL (1) IL202598A (de)
MX (1) MX2009013009A (de)
PL (1) PL2183599T3 (de)
PT (1) PT2183599E (de)
RS (1) RS52124B (de)
RU (1) RU2461837C2 (de)
SI (1) SI2183599T1 (de)
WO (1) WO2009015696A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011033046A1 (en) 2009-09-18 2011-03-24 Probiodrug Ag Novel assay for the detection of amyloid beta peptides
BR112012014060B8 (pt) * 2009-12-11 2021-07-27 Araclon Biotech Sl método para o diagnóstico da doença de alzheimer em um sujeito, para detecção da disfunção cognitiva branda ou para diferenciar a doença de alzheimer da disfunção cognitiva branda
CN102192985A (zh) * 2010-03-18 2011-09-21 上海依科赛生物制品有限公司 一种人体β淀粉样蛋白试剂盒
KR101352670B1 (ko) * 2010-06-15 2014-01-17 울산대학교 산학협력단 알츠하이머 전구단백질 분비 펩타이드의 축적물을 포함하는 뇌 노화 감별 진단 마커
EP2556378B1 (de) * 2010-07-26 2016-05-18 SNU R & DB Foundation Echtzeitüberwachung der entladung von blutproteinen mit hoher dichte oder der wiederherstellung von blutproteinen mit geringer dichte durch uv-spektrometrie
WO2012054333A2 (en) * 2010-10-20 2012-04-26 Merck Sharp & Dohme Corp. Methods for identifying inhibitors of abeta42 oligomers
EP2511296A1 (de) * 2011-04-12 2012-10-17 Araclón Biotech, S. L. Antikörper, Kit und Verfahren zur Bestimmung von Amyloidpeptiden
US20140086836A1 (en) * 2011-05-03 2014-03-27 Mental Health Research Institute Method for detection of a neurological disease
JP6231263B2 (ja) * 2012-07-17 2017-11-15 株式会社島津製作所 アフィニティ支持体及びそれを用いた物質の捕捉方法
JP7434144B2 (ja) * 2018-02-27 2024-02-20 株式会社島津製作所 ＡＰＰ６６９－ｘのＮ末端を特異的に認識する抗体、及び免疫測定法
JP7629278B2 (ja) * 2020-06-25 2025-02-13 シスメックス株式会社 Ａβペプチドを測定するための抗体セット、Ａβペプチドの測定方法及び試薬キット
CN113884683A (zh) * 2020-07-30 2022-01-04 山东京济生物工程有限公司 一种快速检测Aβ42的双抗体夹心ELISA试剂盒
CN114966047A (zh) * 2022-05-10 2022-08-30 上海科华生物工程股份有限公司 一种检测阿尔茨海默病的化学发光试剂盒及其制备方法
CN115932241A (zh) * 2022-12-30 2023-04-07 深圳市天大生物医疗器械有限公司 一种Aβ1-42检测用检测试剂卡及其制备方法与应用
CN118294655A (zh) * 2024-04-12 2024-07-05 上海硅羿生物技术有限公司 一种用于Aβ40/42免疫层析联合定量检测的试剂条及其制备方法
CN118359697A (zh) * 2024-04-29 2024-07-19 上海硅羿生物技术有限公司 β淀粉样蛋白40及β淀粉样蛋白42特异识别多肽及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
AU7121191A (en) * 1990-02-26 1991-10-10 Albert Einstein College Of Medicine Of Yeshiva University Diagnostic assay for alzheimer's disease
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
US7964192B1 (en) * 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
DE69928809T2 (de) * 1998-07-03 2006-08-31 Innogenetics N.V. Differentielle diagnose von neurodegeneration
AU2001269127A1 (en) * 2000-07-06 2002-01-14 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel app mutation associated with an unusual alzheimer's disease pathology
EP1371986A1 (de) * 2002-06-06 2003-12-17 ABETA GmbH Diagnose von Alzheimer basiert auf dem hAbeta42:hAbeta40 Verhältnis
TWI306458B (en) * 2003-05-30 2009-02-21 Elan Pharma Int Ltd Humanized antibodies that recognize beta amyloid peptide
EP1879613B1 (de) * 2005-05-05 2011-11-30 Merck Sharp & Dohme Corp. Peptid-konjugat-zusammensetzungen und -verfahren zur prävention und behandlung von alzheimer-krankheit

Also Published As

Publication number Publication date
CN101861521B (zh) 2014-03-12
SI2183599T1 (sl) 2012-03-30
WO2009015696A1 (en) 2009-02-05
BRPI0721871A2 (pt) 2014-02-18
PL2183599T3 (pl) 2012-04-30
CY1112553T1 (el) 2016-02-10
EP2183599A1 (de) 2010-05-12
ES2377151T3 (es) 2012-03-22
KR101461538B1 (ko) 2014-11-14
IL202598A (en) 2015-10-29
EP2183599B1 (de) 2011-11-09
US20090035790A1 (en) 2009-02-05
AR064186A1 (es) 2009-03-18
CA2689024A1 (en) 2009-02-05
HRP20120020T1 (hr) 2012-03-31
CA2689024C (en) 2015-02-24
KR20100046168A (ko) 2010-05-06
JP5657382B2 (ja) 2015-01-21
RU2009143671A (ru) 2011-05-27
DK2183599T3 (da) 2012-02-27
AU2007357025A1 (en) 2009-02-05
JP2010535328A (ja) 2010-11-18
PT2183599E (pt) 2012-02-13
US20190178899A1 (en) 2019-06-13
RU2461837C2 (ru) 2012-09-20
CL2007003513A1 (es) 2009-02-06
CN101861521A (zh) 2010-10-13
EP2020602A1 (de) 2009-02-04
MX2009013009A (es) 2010-03-29
IL202598A0 (en) 2010-06-30
RS52124B (sr) 2012-08-31
AU2007357025B2 (en) 2014-10-23

Similar Documents

Publication Publication Date Title
ATE533059T1 (de) Hochempfindliche immuntests und kits zur bestimmung von peptiden und proteinen von biologischem interesse
EP2158328A4 (de) Schnelle proteinmarkierung und analyse
EP2307049A4 (de) Nicht hämolytische llo-fusionsproteine und verfahren zu ihrer verwendung
DE602005012555D1 (de) Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon
DK1844074T3 (da) Humane antistoffer og proteiner
HRP20182195T1 (hr) Sekvence aminokiselina usmjerene protiv virusnih proteina ovojnice i polipeptidi koji sadrže iste za liječenje virusnih bolesti
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
CU23869B1 (es) Anticuerpos anti-esclerostina y proteínas funcionales
PT2573114T (pt) Identificação e manipulação de anticorpos com regiões fc variantes e métodos de utilização dos mesmos
EP1711650A4 (de) Mikrofluidische proteinkristallographiemethoden
DE602006018816D1 (de) Gerät und Methode zur Messung von Eingeweidenfett
DE112005002192A5 (de) Kraftauswertevorrichtung und Kraftauswerteverfahren zur Bestimmung von Gleichgewichtskenngrössen
BRPI0918233B8 (pt) métodos de triagem para a lesão pulmonar aguda e doença do enxerto contra hospedeiro relacionada à transfusão ou transplante, kits e uso de polipeptídeos
BRPI0907864A2 (pt) Identificação de proteínas de ligação específicas para antígenos ou ligandos
EP2233927A4 (de) Verfahren zur messung von endotoxin und reagenzienkit zur messung von endotoxin
EP1877785A4 (de) Verfahren zur messung der glycanniveaus von proteinen
DK1904627T3 (da) Fremgangsmåde til fremstilling af prrs-virus og proteiner og diagnostiske testkits til detektion deraf
EP1789788A4 (de) Immobilisierte proben und verfahren zur detektion von konformativ veränderten prion-proteinen
DE602006018721D1 (de) Cyanidfreie lösungsmittelzusammensetzung und verwendungsverfahren dafür zur messung von hämoglobin und weissen blutkörperchen
DK2547694T5 (da) Hidtil ukendt signalpeptid og anvendelse deraf til fremstilling af rekombinante proteiner
EP1753871A4 (de) An psca-proteine bindende antikörper und verwandte moleküle
EP4446339A4 (de) Antikörper zur erkennung des rsv-pre-f-proteins und verwendung davon
DE112004002986A5 (de) Prüfanlage zur zerstörungsfreien Materialprüfung
EP1769244A4 (de) Nachweis oder messung von antigenprotein-antikörpern in biologischen geweben oder proben
DE602005014715D1 (de) Methode zur Messung von Haut Anisotropie